We are live on ! Find out more
DGX icon

Quest Diagnostics

496 hedge funds and large institutions have $8.72B invested in Quest Diagnostics in 2014 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 174 increasing their positions, 176 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

49% more call options, than puts

Call options by funds: $160M | Put options by funds: $108M

20% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 45

17% more funds holding in top 10

Funds holding in top 10: 67 (+1)

1% more funds holding

Funds holding: 491496 (+5)

2% more capital invested

Capital invested by funds: $8.54B → $8.72B (+$185M)

1% less repeat investments, than reductions

Existing positions increased: 174 | Existing positions reduced: 176

1.91% less ownership

Funds ownership: 104.75%102.83% (-1.9%)

Holders
496
Holders Change
+5
Holders Change %
+1.02%
% of All Funds
14.26%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.2%
New
54
Increased
174
Reduced
176
Closed
45
Calls
$160M
Puts
$108M
Net Calls
+$52.2M
Net Calls Change
+$263M
Name Holding Trade Value Shares
Change
Change in
Stake
Zurich Cantonal Bank
301
Zurich Cantonal Bank
Switzerland
$666K -$3.01M -51,483 -82%
TFA
302
Transamerica Financial Advisors
Florida
$664K +$36.4K +621 +6%
LSERS
303
Louisiana State Employees Retirement System
Louisiana
$663K -$5.86K -100 -0.9%
IMS
304
Index Management Solutions
Pennsylvania
$660K +$63.4K +1,082 +11%
SCM
305
Stevens Capital Management
Pennsylvania
$652K +$650K +11,105 New
WMSA
306
Weiss Multi-Strategy Advisers
New York
$649K +$64.4K +1,100 +11%
CI
307
Conning Inc
Connecticut
$646K -$22.3K -380 -3%
HPC
308
HM Payson & Co
Maine
$645K
BPBT
309
Boston Private Bank & Trust
Massachusetts
$641K -$135K -2,300 -17%
ANI
310
American National Insurance
Texas
$640K
CCFCSB
311
Cape Cod Five Cents Savings Bank
Massachusetts
$635K -$10.5K -180 -2%
MIM
312
Montgomery Investment Management
Maryland
$631K -$111K -1,900 -15%
VHAM
313
Van Hulzen Asset Management
California
$616K +$117 +2 +0%
WCM
314
Wedge Capital Management
North Carolina
$612K +$228K +3,900 +60%
MAM
315
Meeder Asset Management
Ohio
$593K +$53.3K +910 +10%
ERSOT
316
Employees Retirement System of Texas
Texas
$587K -$176K -3,000 -23%
CT
317
Coastline Trust
Rhode Island
$586K +$34.3K +585 +6%
B
318
Barings
North Carolina
$584K +$11.7K +200 +2%
SM
319
Stratton Management
Pennsylvania
$581K -$3.04K -52 -0.5%
N
320
Nuveen
North Carolina
$576K -$23.6K -403 -4%
ID
321
Integral Derivatives
New York
$559K +$558K +9,523 New
Capital Fund Management (CFM)
322
Capital Fund Management (CFM)
France
$554K -$9.09M -155,200 -94%
Mackenzie Financial
323
Mackenzie Financial
Ontario, Canada
$554K +$225K +3,846 +69%
Commonwealth Equity Services
324
Commonwealth Equity Services
Massachusetts
$550K +$30K +513 +6%
RFS
325
Rockefeller Financial Services
New York
$549K -$856K -14,620 -61%

DGX Hedge Fund Activity: Q2 2014 in Review

496 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q2 2014, worth a combined $8.72B — up 2.2% from $8.54B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new DGX positions and 45 closed out — a net gain of 9 holders — while 174 added to existing stakes and 176 trimmed.

The largest buyer was Bank of America, adding an estimated $341M. The largest seller was Aberdeen Asset Management, cutting an estimated $386M.

  • 496 institutional investors held Quest Diagnostics (DGX) as of Q2 2014, up from 491 in Q1 2014.
  • Funds reported $8.72B of Quest Diagnostics stock for Q2 2014, up 2.2% quarter-over-quarter.
  • 54 funds opened new Quest Diagnostics positions in Q2 2014 and 45 closed out, a net change of +9 holders.
  • The largest Quest Diagnostics buyer in Q2 2014 was Bank of America, an estimated $341M added.
  • The largest Quest Diagnostics seller in Q2 2014 was Aberdeen Asset Management, an estimated $386M sold.

Based on aggregated 13F filings for Q2 2014.